Drug Safety Assessment and Risk Minimization in the Development Period - Webinar By ComplianceOnline
Submitted by Admin on Fri, 10/22/2010 - 02:43
10/26/2010 10:00 am
10/26/2010 11:00 am
US/Pacific
This drug safety training will discuss the various factors to be considered and the principles of risk assessment to be followed during drug development to minimize risk.
Areas Covered in the Seminar:
- Risk conceptualization.
- Goals of project risk management.
- Risk management planning & safety review teams.
- Intellectual property.
- Pharmacovigilance planning in product risk management.
- Unexpected study results: efficacy, dosage, adverse events & toxicology.
- Data analysis, interpretation and presentation.
- Essentials of Data Monitoring Committees.
- Drug disposal and environmental impact.
- Labeling as a hallmark of risk management efforts.
- Post-marketing risk.
Who Will Benefit: The Webinar will present valuable risk management information and provide a familiarity with practices to mitigate risk by pharmaceutical and biotechnology personnel involved in drug development, including:
- Project managers
- Managers in drug development
- Clinical research associates
- Regulatory and safety managers
- Compliance associates
Webinar Presenters:
ComplianceOnline Instructor - Dr. Sheldon Brookman

